Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Conte

Showing results (161-170 of 246) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis and Related Disorders|November 6, 2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedulesGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Scientific Reports|July 31, 2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing offGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Multiple Sclerosis and Related Disorders|February 23, 2020
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?Carla Prezioso, Maria Antonella Zingaropoli, Marco Iannetta, et al.
European Journal of Neurology|June 9, 2023
Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotypeAurora Zanghì, Simonetta Galgani, Paolo Bellantonio, et al.
International Journal of Molecular Sciences|May 11, 2024
Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson's DiseaseMatteo Costanzo, Eleonora Galosi, Maria Ilenia De Bartolo, et al.
Scientific Reports|December 30, 2025
Early functional network alterations predict motor and cognitive decline in parkinson's diseaseSara Pietracupa, Claudia Piervincenzi, Daniele Belvisi, et al.
Parkinsonism & Related Disorders|April 29, 2022
Neurofilament assessment in patients with cervical dystoniaGina Ferrazzano, Maria Antonella Zingaropoli, Matteo Costanzo, et al.
Scientific Reports|May 11, 2021
Salivary caffeine in Parkinson's diseaseGiorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, et al.
Marine Pollution Bulletin|April 9, 2019
Heavy metal tolerance and polychlorinated biphenyl oxidation in bacterial communities inhabiting the Pasvik River and the Varanger Fjord area (Arctic Norway)Alessandro Ciro Rappazzo, Maria Papale, Carmen Rizzo, et al.
Geroscience|February 23, 2026
Relationship between frailty and disease progression in Parkinson's disease: a 3-year longitudinal studyMatteo Costanzo, Marco Canevelli, Maria Ilenia De Bartolo, et al.
Pageof 25

Showing results (161-170 of 246) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis and Related Disorders|November 6, 2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedulesGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Scientific Reports|July 31, 2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing offGiorgio Leodori, Marco Mancuso, Davide Maccarrone, et al.
Multiple Sclerosis and Related Disorders|February 23, 2020
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?Carla Prezioso, Maria Antonella Zingaropoli, Marco Iannetta, et al.
European Journal of Neurology|June 9, 2023
Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotypeAurora Zanghì, Simonetta Galgani, Paolo Bellantonio, et al.
International Journal of Molecular Sciences|May 11, 2024
Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson's DiseaseMatteo Costanzo, Eleonora Galosi, Maria Ilenia De Bartolo, et al.
Scientific Reports|December 30, 2025
Early functional network alterations predict motor and cognitive decline in parkinson's diseaseSara Pietracupa, Claudia Piervincenzi, Daniele Belvisi, et al.
Parkinsonism & Related Disorders|April 29, 2022
Neurofilament assessment in patients with cervical dystoniaGina Ferrazzano, Maria Antonella Zingaropoli, Matteo Costanzo, et al.
Scientific Reports|May 11, 2021
Salivary caffeine in Parkinson's diseaseGiorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, et al.
Marine Pollution Bulletin|April 9, 2019
Heavy metal tolerance and polychlorinated biphenyl oxidation in bacterial communities inhabiting the Pasvik River and the Varanger Fjord area (Arctic Norway)Alessandro Ciro Rappazzo, Maria Papale, Carmen Rizzo, et al.
Geroscience|February 23, 2026
Relationship between frailty and disease progression in Parkinson's disease: a 3-year longitudinal studyMatteo Costanzo, Marco Canevelli, Maria Ilenia De Bartolo, et al.
Pageof 25